A nomogram model will be established to predict the 2-year, 4-year, and 6-year survival probability of patients by integrating clinicopathological factors (including age, sex, tumor differentiation, and clinicopathological stage) and NOLC1 expression, and a calibration model will be established to test the reliability of the nomogram model (Fig. 2i, j). Here, NOLC1 is linked to neoplasm.